|
EP2298863B1
(en)
|
2004-03-22 |
2015-07-22 |
Mesoblast International Sàrl |
Mesenchymal stem cells and uses therefor
|
|
EP1729788B1
(en)
*
|
2004-03-30 |
2009-11-25 |
Boston Scientific Limited |
Restenosis therapy using mesenchymal stem cells
|
|
US20060045872A1
(en)
|
2004-08-25 |
2006-03-02 |
Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco |
Use of adipose tissue-derived stromal stem cells in treating fistula
|
|
CA2623353C
(en)
|
2005-09-23 |
2017-02-21 |
Cellerix, S.L. |
Cell populations having immunoregulatory activity, method for isolation and uses
|
|
CA2624925C
(en)
|
2005-10-13 |
2014-09-30 |
Anthrogenesis Corporation |
Immunomodulation using placental stem cells
|
|
ES2708933T3
(es)
|
2005-12-29 |
2019-04-12 |
Celularity Inc |
Poblaciones de células madre placentarias
|
|
EP3287520A1
(en)
|
2006-01-13 |
2018-02-28 |
Mesoblast International Sàrl |
Mesenchymal stem cells expressing tnf-alpha receptors
|
|
KR101569168B1
(ko)
|
2007-02-12 |
2015-11-13 |
안트로제네시스 코포레이션 |
태반 줄기세포를 이용한 염증 질환의 치료
|
|
JP5541845B2
(ja)
*
|
2008-03-28 |
2014-07-09 |
Ｊｃｒファーマ株式会社 |
アトピー性皮膚炎治療剤
|
|
US20110150845A1
(en)
*
|
2008-05-02 |
2011-06-23 |
Massachusetts Institute Of Technology |
Methods and compositions for modulating immunological tolerance
|
|
GB0814249D0
(en)
*
|
2008-08-04 |
2008-09-10 |
Cellerix Sa |
Uses of mesenchymal stem cells
|
|
DK2330889T3
(en)
|
2008-08-20 |
2017-01-30 |
Anthrogenesis Corp |
Improved cell composition and process for making the same
|
|
HRP20130812T1
(en)
|
2008-08-22 |
2013-09-30 |
Anthrogenesis Corporation |
Methods and compositions for treatment of bone defects with placental cell populations
|
|
BRPI0919804A8
(pt)
*
|
2008-10-05 |
2016-10-11 |
Friedlander Hymie |
Métodos e composição para o tratamento de problemas dermatológicos e/ou condições de cabelo
|
|
CN102282252B
(zh)
|
2008-11-19 |
2017-07-04 |
人类起源公司 |
羊膜来源的贴壁细胞
|
|
EP2456853B1
(en)
*
|
2009-07-21 |
2020-10-28 |
ABT Holding Company |
Use of stem cells to reduce leukocyte extravasation
|
|
WO2011070974A1
(ja)
*
|
2009-12-07 |
2011-06-16 |
国立大学法人名古屋大学 |
脂肪組織由来間葉系幹細胞を含有する、前立腺癌治療用細胞製剤
|
|
EP2512516B1
(en)
*
|
2009-12-18 |
2016-02-17 |
The Governing Council Of The University Of Toronto |
Injectable polymer composition for use as a cell delivery vehicle
|
|
MX2012011543A
(es)
|
2010-04-08 |
2013-05-06 |
Anthrogenesis Corp |
Tratamiento de sarcoidosis empleando celulas madre placentarias.
|
|
KR101677293B1
(ko)
*
|
2010-04-16 |
2016-11-17 |
서울대학교병원 |
줄기세포의 활성을 증가시키는 방법 및 상기 방법에 의해 제조된 고활성 줄기 세포
|
|
DK2568991T6
(en)
|
2010-05-12 |
2019-03-18 |
Abt Holding Co |
MODULATION OF SPLENOCYTES IN CELL THERAPY
|
|
EP4663241A3
(en)
|
2010-10-08 |
2026-03-25 |
Mesoblast International Sàrl |
Enhanced msc preparations
|
|
CN101991878A
(zh)
*
|
2010-11-08 |
2011-03-30 |
中国人民解放军军事医学科学院基础医学研究所 |
由复合msc的plga和msc组成的制剂及其应用
|
|
CN101991880A
(zh)
*
|
2010-11-08 |
2011-03-30 |
中国人民解放军军事医学科学院基础医学研究所 |
由复合msc的plga/tcp和msc组成的制剂及其应用
|
|
AU2011352036A1
(en)
|
2010-12-31 |
2013-07-18 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory RNA molecules
|
|
US9901600B2
(en)
*
|
2011-03-11 |
2018-02-27 |
Children's Medical Center Corporation |
Methods and compositions relating to mesenchymal stem cell exosomes
|
|
CN104220081A
(zh)
|
2011-06-01 |
2014-12-17 |
人类起源公司 |
利用胎盘干细胞治疗疼痛
|
|
RS57886B1
(sr)
*
|
2011-11-30 |
2019-01-31 |
Astellas Inst For Regenerative Medicine |
Mezenhimalne stromalne ćelije i primene vezane za njih
|
|
US8961956B2
(en)
|
2011-11-30 |
2015-02-24 |
Ocata Therapeutics, Inc. |
Mesenchymal stromal cells and uses related thereto
|
|
CN103191154B
(zh)
*
|
2012-01-06 |
2015-09-09 |
上海交通大学医学院 |
充质干细胞及其提取方法在制备银屑病的药物中的应用
|
|
WO2014098960A2
(en)
*
|
2012-05-16 |
2014-06-26 |
The Johns Hopkins University |
Stem cells as an individualized maternal therapy for prevention of prematurity
|
|
CA2876499C
(en)
|
2012-07-12 |
2021-10-26 |
Imstem Biotechnology, Inc. |
Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
|
|
CA2893942C
(en)
*
|
2012-12-12 |
2023-03-28 |
Mesoblast, Inc. |
Treatment of diseases of endothelial dysfunction and inflammation
|
|
JP6313327B2
(ja)
*
|
2012-12-12 |
2018-04-18 |
メソブラスト、インコーポレイテッド |
呼吸器系疾患を治療又は予防する方法
|
|
US10357538B2
(en)
*
|
2012-12-24 |
2019-07-23 |
Northern Sydney Local Health District |
Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
|
|
JP6571537B2
(ja)
*
|
2013-03-13 |
2019-09-04 |
ザ ユニバーシティー オブ クイーンズランド |
療法および予防のための細胞を単離する方法
|
|
PT2983680T
(pt)
|
2013-04-12 |
2020-10-29 |
Abt Holding Co |
Melhoria de órgãos para transplante
|
|
US20160120910A1
(en)
*
|
2013-06-25 |
2016-05-05 |
Tigenix S.A.U. |
Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
|
|
CN106255884B
(zh)
*
|
2013-10-04 |
2019-01-11 |
赛尔爱迪尔私人有限公司 |
用于细胞治疗的生物标志物
|
|
JP6210049B2
(ja)
|
2014-11-04 |
2017-10-11 |
トヨタ自動車株式会社 |
車両
|
|
LT3242933T
(lt)
*
|
2015-01-08 |
2019-06-25 |
Apceth Gmbh & Co. Kg |
Genetiškai modifikuotos mezenchiminės kamieninės ląstelės, ekspresuojančios alfa-1 antitripsiną (aat)
|
|
WO2016146819A1
(en)
*
|
2015-03-18 |
2016-09-22 |
Apceth Gmbh & Co. Kg |
Hypoxia-induced expression of therapeutic proteins in mesenchymal stem cells
|
|
JP6811724B2
(ja)
*
|
2015-04-24 |
2021-01-13 |
ティジェニクス エス．エー．ユー． |
細胞療法に対する臨床応答を決定するためのバイオマーカー
|
|
CN108700565B
(zh)
|
2015-10-07 |
2021-10-29 |
善威生物私人有限公司 |
血液制备和图谱分析
|
|
CA3009369A1
(en)
*
|
2015-12-22 |
2017-06-29 |
Sangui Bio Pty. Ltd |
Therapeutic methods using erythrocytes
|
|
GB201604304D0
(en)
|
2016-03-14 |
2016-04-27 |
Tigenix S A U |
Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
|
|
CN105769911A
(zh)
*
|
2016-03-23 |
2016-07-20 |
中国人民解放军第二军医大学 |
间充质干细胞诱导斑秃处毛发再生的方法及应用
|
|
KR101970642B1
(ko)
*
|
2016-04-06 |
2019-05-17 |
주식회사 제이제이메이딘 |
줄기세포 배양용 배지조성물 및 그를 이용한 줄기세포 배양방법
|
|
EP3450548A4
(en)
|
2016-04-27 |
2019-11-20 |
Rohto Pharmaceutical Co., Ltd. |
MESCHYMAL STEM CELL FOR EXPRESSING AT LEAST ONE CELL SURFACE MARKER SELECTED FROM THE GROUP OF CD201, CD46, CD56, CD147 AND CD165, AND METHOD FOR THE MANUFACTURE THEREOF AND PHARMACEUTICAL COMPOSITION WITH THE MESENCHYMAL STEM CELL AND METHOD FOR THE PRODUCTION THEREOF
|
|
EP3494977A4
(en)
|
2016-08-05 |
2020-03-18 |
Exostemtech Co., Ltd. |
COMPOSITION FOR THE PREVENTION OR TREATMENT OF LUNG FIBROSE WITH FAT TISSUE EXOSOM OBTAINED FROM STEM CELLS AS AN ACTIVE SUBSTANCE
|
|
CN109952371A
(zh)
|
2016-11-15 |
2019-06-28 |
株式会社钟化 |
包含来自胎儿附属物的间充质系干细胞的细胞群、其制备方法、以及医药组合物
|
|
CN106492194A
(zh)
*
|
2016-11-30 |
2017-03-15 |
广州赛莱拉干细胞科技股份有限公司 |
一种干细胞外泌体制剂及其制备方法和应用
|
|
WO2018112500A1
(en)
|
2016-12-20 |
2018-06-28 |
Sangui Bio Pty. Ltd |
Blood profiling with protease inhibitors
|
|
CN110139657A
(zh)
*
|
2017-02-15 |
2019-08-16 |
日本乐敦制药株式会社 |
肺纤维化治疗剂、ptprr表达促进剂及肺纤维化治疗用试剂盒
|
|
AU2018234827B2
(en)
|
2017-03-15 |
2024-04-04 |
Orca Biosystems Inc. |
Compositions and methods for hematopoietic stem cell transplants
|
|
AU2018372631B2
(en)
|
2017-11-22 |
2025-06-05 |
Mesoblast International Sarl |
Cellular compositions and methods of treatment I
|
|
WO2019132026A1
(ja)
|
2017-12-28 |
2019-07-04 |
株式会社カネカ |
接着性幹細胞を含む細胞集団とその製造方法、及び医薬組成物
|
|
CN108451981B
(zh)
*
|
2018-04-21 |
2019-07-23 |
江西汉氏联合干细胞科技有限公司 |
使用皮肤间充质干细胞治疗系统性硬化症
|
|
WO2020015264A1
(zh)
*
|
2018-07-17 |
2020-01-23 |
北京三有利和泽生物科技有限公司 |
牙源干细胞及其用途
|
|
WO2020182935A1
(en)
*
|
2019-03-12 |
2020-09-17 |
Global Stem Cell Technology |
Immunomodulating mesenchymal stem cells
|
|
US20220175666A1
(en)
*
|
2019-03-21 |
2022-06-09 |
Anterogen Co., Ltd. |
Injection formulation composition containing mesenchymal stem cell-hydrogel and method for preparing, freezing and defrosting same
|
|
WO2020251020A1
(ja)
|
2019-06-14 |
2020-12-17 |
株式会社カネカ |
間葉系細胞を含む細胞集団、それを含む医薬組成物、及び、その製造方法
|
|
CN110772537A
(zh)
*
|
2019-11-07 |
2020-02-11 |
深圳科康干细胞技术有限公司 |
脐带血间充质干细胞组合物在治疗慢性阻塞性肺疾病中的应用
|
|
WO2021176001A1
(en)
*
|
2020-03-05 |
2021-09-10 |
Mesoblast International Sàrl |
Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells
|
|
CA3173216A1
(en)
*
|
2020-04-03 |
2021-10-07 |
Silviu Itescu |
Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells
|
|
US20210315937A1
(en)
*
|
2020-04-08 |
2021-10-14 |
University Of South Florida |
Methods of treating inflammation
|
|
WO2021226373A2
(en)
|
2020-05-08 |
2021-11-11 |
Gallant Pet, Inc. |
Uterine-derived regenerative cell compositions and uses thereof
|
|
EP3909594A1
(en)
*
|
2020-05-14 |
2021-11-17 |
Bernat Soria Escoms |
Mesenchymal stromal cells for the treatment of covid-19 and other inflammatory, autoimmune and degenerative diseases
|
|
CN111568930A
(zh)
*
|
2020-05-23 |
2020-08-25 |
湖南源品细胞生物科技有限公司 |
一种msc用于调节nk细胞数量的应用
|
|
IL299997A
(en)
*
|
2020-07-20 |
2023-03-01 |
Brainstorm Cell Therapeutics Ltd |
Methods and preparations for the treatment of lung conditions
|
|
CN112076217A
(zh)
*
|
2020-10-26 |
2020-12-15 |
重庆医科大学附属第一医院 |
一种间充质干细胞来源的抗炎症氧化脂质组合物的制备方法
|
|
IL302833A
(en)
|
2020-11-13 |
2023-07-01 |
Advanced Therapeutic Lab Inc |
Medicinal compositions and methods using SVF derived from adipose tissue
|
|
AU2023323861A1
(en)
*
|
2022-08-11 |
2025-02-27 |
Boehringer Ingelheim Vetmedica Gmbh |
Mesenchymal stem cells for use in the treatment of insect-bite hypersensitivity in equines
|
|
CN117398450B
(zh)
*
|
2023-10-31 |
2025-03-11 |
北京三有利和泽生物科技有限公司 |
过表达肝细胞生长因子的间充质干细胞在制备哮喘药物中的应用
|